Source:http://linkedlifedata.com/resource/pubmed/id/11355564
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2001-5-17
|
pubmed:abstractText |
A randomized controlled trial in KwaZulu-Natal (South Africa) of 428 primary-school pupils (stratified into 6 groups by age, sex and intervention) measured the effect of different anthelmintic treatments and iron supplementation regimens provided twice at 6-monthly intervals for 1 year (1996/97). Half the pupils received iron supplementation (ferrous fumarate 200 mg weekly for 10 weeks). Pupils received 2 anthelmintic regimens, either (i) albendazole 400 mg plus praziquantel 40 mg/kg or (ii) albendazole 400 mg on 3 consecutive days plus praziquantel 40 mg/kg or (iii) placebo. Baseline prevalences of Ascaris 55.9%, Trichuris 83.6%, hookworm spp. 59.4%, were reduced after 12 months for single-dose albendazole treatment to Ascaris 17.4% (P < 0.005), Trichuris 61.5% (NS), hookworm spp. 0% (P < 0.005), and for triple-dose albendazole treatment to Ascaris 14.8% (P < 0.005), Trichuris 25.0% (P < 0.01), hookworm 0% (P < 0.005). Schistosoma haematobium 43.4% was reduced among treated groups to 8.3% (P < 0.005). There were no significant changes in the anthropometry of the different treatment groups at either 6 or 12 months post treatment. Twelve months after treatment there was a significant increase in haemoglobin levels (P = 0.02) among pupils receiving triple-dose albendazole, praziquantel and ferrous fumarate; pupils receiving no anthelmintic treatment showed a significant decrease as did pupils who received triple-dose albendazole and praziquantel but no iron. Regular 6-monthly anthelmintic treatment significantly reduced the prevalence of Ascaris, hookworm spp. and S. haematobium infections (P < 0.05). Triple-dose treatment for Trichuris was significantly more effective than a single dose of albendazole 400 mg (P = 0.002). In areas with schistosomiasis, hookworm infection and high prevalence of Trichuris infection, combination treatment with praziquantel, triple-dose albendazole, plus iron supplementation, is likely to improve pupils' health and haemoglobin levels.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Albendazole,
http://linkedlifedata.com/resource/pubmed/chemical/Anthelmintics,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobins,
http://linkedlifedata.com/resource/pubmed/chemical/Iron,
http://linkedlifedata.com/resource/pubmed/chemical/Praziquantel
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0035-9203
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
95
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
211-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11355564-Adolescent,
pubmed-meshheading:11355564-Albendazole,
pubmed-meshheading:11355564-Anemia,
pubmed-meshheading:11355564-Anthelmintics,
pubmed-meshheading:11355564-Ascariasis,
pubmed-meshheading:11355564-Body Height,
pubmed-meshheading:11355564-Child,
pubmed-meshheading:11355564-Double-Blind Method,
pubmed-meshheading:11355564-Drug Combinations,
pubmed-meshheading:11355564-Female,
pubmed-meshheading:11355564-Helminthiasis,
pubmed-meshheading:11355564-Hemoglobins,
pubmed-meshheading:11355564-Humans,
pubmed-meshheading:11355564-Iron,
pubmed-meshheading:11355564-Male,
pubmed-meshheading:11355564-Praziquantel,
pubmed-meshheading:11355564-Regression Analysis,
pubmed-meshheading:11355564-Risk Factors,
pubmed-meshheading:11355564-Schistosomiasis haematobia,
pubmed-meshheading:11355564-Trichuriasis
|
pubmed:articleTitle |
The effect of different anthelmintic treatment regimens combined with iron supplementation on the nutritional status of schoolchildren in KwaZulu-Natal, South Africa: a randomized controlled trial.
|
pubmed:affiliation |
Departments of Community Health and Haematology, Faculty of Medicine, University of Natal, Private Bag 7, Congella 4013, South Africa. taylor@med.und.ac.za
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|